LOX: Catheters, Transluminal Coronary Angioplasty, Percutaneous
What it covers
A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end.
FDA’s definition of product code LOX, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K261428 | NC Euphora Rapid Exchange Balloon Dilatation Catheter | Medtronic Ireland | Aug 14, 2026 | Traditional |
| K261759 | Euphora Rapid Exchange (RX) Balloon Dilatation Catheter | Medtronic Ireland | Jul 27, 2026 | Traditional |
| K252116 | Firefighter Pro PTCA Balloon Catheter | Shanghai MicroPort Medical (Group) Co., Ltd. | Apr 7, 2026 | Traditional |
| K254022 | FLASH Flex Aorto-Ostial Angioplasty System | Verge Medical, Inc. | Apr 2, 2026 | Traditional |
| K252295 | Ryurei | Terumo Corporation | Mar 27, 2026 | Traditional |
| K251970 | Sprinter Legend Rapid Exchange Balloon Dilatation Catheter | Medtronic, Ireland | Jan 17, 2026 | Traditional |
| K242969 | Pantera Pro; Pantera LEO | Biotronik, Inc. | Oct 25, 2024 | Special |
| K233499 | Sapphire NC ULTRA Coronary Dilatation Catheter | OrbusNeich Medical (Shenzhen) Co., Ltd. | Aug 16, 2024 | Traditional |
| K233505 | Sapphire ULTRA Coronary Dilatation Catheter | OrbusNeich Medical (Shenzhen) Co., Ltd. | Aug 15, 2024 | Traditional |
| K233729 | Ringer perfusion balloon catheter, 2.00 x 20mm (5881); Ringer perfusion balloon catheter, 2.50 x 20mm (5882); Ringer perfusion balloon catheter, 2.50 x 30mm (5883); Ringer perfusion balloon catheter, 3.00 x 20mm (5884); Ringer perfusion balloon catheter, 3.00 x 30mm (5885); Ringer perfusion balloon catheter, 3.50 x 20mm (5886); Ringer perfusion balloon catheter, 3.50 x 30mm (5887); Ringer perfusion balloon catheter, 4.00 x 20mm (5888); Ringer perfusion balloon catheter, 4.00 x 30mm (58 | Vascular Solutions, LLC | May 31, 2024 | Traditional |
Clearances by year
82 LOX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 6 | 156 |
| 2024 | 4 | 241 |
| 2023 | 4 | 138 |
| 2022 | 5 | 121 |
| 2021 | 6 | 167 |
| 2020 | 1 | 29 |
| 2019 | 1 | 21 |
| 2018 | 7 | 80 |
| 2017 | 6 | 113 |
| 2016 | 9 | 116 |
| 2015 | 4 | 119 |
| 2014 | 6 | 166 |
| 2013 | 6 | 123 |
| 2012 | 10 | 120 |
| 2011 | 7 | 103 |
Who submits
34 applicants cleared a LOX device since 2011. 57% of the clearances went to applicants in United States, then China (23%), Ireland (7%) and Japan (5%). By type: Traditional 76% and Special 24%.
| Applicant | Clearances since 2011 |
|---|---|
| Abbott Vascular | 6 |
| Boston Scientific Corporation | 6 |
| Ostial Corporation | 5 |
| Orbusneich Medical Trading, Inc. | 4 |
| Orbusneich Medical, Inc. | 4 |
| Biotronik, Inc. | 3 |
| Boston Scientific Corp | 3 |
| Brosmed Medical Co., Ltd. | 3 |
How FDA classifies it
(b) Cutting/scoring PTCA Catheter—(1) Identification. A cutting/scoring PTCA catheter is a balloon-tipped catheter with cutting/scoring elements attached, which is used in those circumstances where a high pressure balloon resistant lesion is encountered. A cutting/scoring PTCA catheter is intended for the treatment of hemodynamically significant coronary artery stenosis for the purpose of improving myocardial perfusion. A cutting/scoring PTCA catheter may also be indicated for use in complex type C lesions or for the treatment of in-stent restenosis.
(2) Classification. Class III (premarket approval). As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 870.3.
From 21 CFR 870.5100. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.5100 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LOX clearances declared.
Ask about LOX
Questions about LOX
What is FDA product code LOX?
Product code LOX, “Catheters, Transluminal Coronary Angioplasty, Percutaneous” in FDA's classification database, is a Class II device type under 21 CFR 870.5100 (percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 88 clearances under LOX, 82 of them since 2011.
How many 510(k) clearances are there under LOX?
FDA’s 510(k) database listed 88 clearances under LOX as of Oct 29, 2026, 82 of them decided since 2011; the most recent decision was Aug 14, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LOX 510(k)?
For the 6 LOX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 156 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LOX clearances?
Since 2011: Abbott Vascular (6), Boston Scientific Corporation (6), Ostial Corporation (5), Orbusneich Medical Trading, Inc. (4) and Orbusneich Medical, Inc. (4). 34 applicants have cleared a LOX device in that time.